General Callout
Nunc dolor esse suscipit eros eros ullamco dolor. Duis velaliquam sunt urna, tempuribud doming quis, laboris ultricies ultricies urna laboris. Nostrud pulvinar nostrud elit sunt ex exercitation magna tempuribud laboris ea ex nunc sed exercitation ea laboris dignissim.
Accordion
Quis harmud ea commodo voluptate dolor urna providerent tempor amet dignissim velit consectetur harmud sint doming, urna magna velit sed commodo urna sint sunt nunc. Nunc consectetur laboris harmud dolore exercitation sed magna laboris nulla velit velaliquam ultricies. Dignissim adipiscing, sed duis ultricies sint voluptate providerent nunc nisi.
Heading 1
Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.
Heading 2
Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.
Call to action
Esse suscipit in eros ea sed voluptate dolore, harmud nisi, dolore ultricies fugiat amet doming ut sint ut adipiscing. Sit velit velaliquam ex nunc ut voluptate
Status:
Negotiations were not pursued
Manufacturer:
Pfizer Canada ULC
Indication:
Acute Myeloid Leukemia (AML)
Last updated February 23, 2021
Status:
Concluded with an LOI
Manufacturer:
Bayer Inc.
Indication:
Non-metastatic Castration-resistant prostate cancer
Last updated February 18, 2021
Status:
Concluded with an LOI
Manufacturer:
Merck Canada Inc.
Indication:
Head and Neck Squamous Cell Carcinoma (HNSCC)
Last updated February 10, 2021
Status:
Concluded with an LOI
Manufacturer:
Pfizer Canada ULC
Indication:
Transthyretin-mediated amyloidosis
Last updated February 4, 2021
Aermony Respiclick (fluticasone propionate)
Status:
Concluded with an LOI
Manufacturer:
Teva Canada Ltd.
Indication:
Asthma
Last updated February 2, 2021
Monoferric (iron (iii) isomaltoside 1000)
Status:
Concluded with an LOI
Manufacturer:
Pharmacosmos A/S
Indication:
Iron Deficiency Anemia
Last updated February 2, 2021
Spravato (esketamine hydrochloride)
Status:
Negotiations were not pursued
Manufacturer:
Janssen Inc.
Indication:
Major Depressive Disorder
Last updated January 27, 2021
Status:
Concluded with an LOI
Manufacturer:
Fresenius Kabi Canada Ltd.
Indication:
Rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, plaque psoriasis, uveitis
Last updated January 26, 2021
Blood glucose test strips (blood glucose test strips)
Status:
Concluded with an LOI
Manufacturer:
Bionime USA Corporation
Indication:
Diabetes Mellitus, Type 1 & 2
Last updated January 22, 2021
Blood glucose test strips (blood glucose test strips)
Status:
Concluded with an LOI
Manufacturer:
ForaCare Technology Canada, Inc.
Indication:
Diabetes Mellitus, Type 1 & 2
Last updated January 22, 2021